EXSERVAN Trademark

Trademark Overview

On Thursday, June 24, 2021, a trademark application was filed for EXSERVAN with the United States Patent and Trademark Office. The USPTO has given the EXSERVAN trademark a serial number of 90792818. The federal status of this trademark filing is REGISTERED as of Tuesday, May 16, 2023. This trademark is owned by Aquestive Therapeutics, Inc.. The EXSERVAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of neurological and central nervous system diseases and disorders; Pharmaceutical preparations for treatment of diseases and disorders of the central nervous system
exservan

General Information

Serial Number90792818
Word MarkEXSERVAN
Filing DateThursday, June 24, 2021
Status700 - REGISTERED
Status DateTuesday, May 16, 2023
Registration Number7056382
Registration DateTuesday, May 16, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Description of MarkThe mark consists of the word "EXSERVAN" in the color blue. There are three overlapping rectangles in the shades of blue, light blue and light green, in the upper right hand corner above the letter "N".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of neurological and central nervous system diseases and disorders; Pharmaceutical preparations for treatment of diseases and disorders of the central nervous system
Indication of Colors claimedThe color(s) blue, light blue, light green is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code005
First Use Anywhere DateWednesday, June 30, 2021
First Use In Commerce DateWednesday, June 30, 2021

Trademark Owner History

Party NameAquestive Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameAquestive Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameAquestive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Monday, June 28, 2021NEW APPLICATION ENTERED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 9, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Monday, March 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 21, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 21, 2022SOU EXTENSION 1 FILED
Wednesday, December 21, 2022USE AMENDMENT FILED
Wednesday, January 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 11, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, February 2, 2023NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 13, 2023ASSIGNED TO EXAMINER
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 7, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 8, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 16, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, July 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

exservan central nervous system pharmaceutical treatment preparations disorders diseases neurological prevention